1. Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration. (1st January 2022) Authors: Ouattara, Louise A.; Thurman, Andrea R.; Jacot, Terry A.; Cottrell, Mackenzie; Sykes, Craig; Blake, Kimberly; Fang, Xi; Ju, Susan; Vann, Nikolas C.; Schwartz, Jill; Doncel, Gustavo F. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 89:Number 1(2022) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genital Mucosal Drug Concentrations and anti-HIV Activity in Tenofovir-Based PrEP Products: Intravaginal Ring vs. Oral Administration. (1st January 2022) Authors: Ouattara, Louise A.; Thurman, Andrea R.; Jacot, Terry A.; Cottrell, Mackenzie; Sykes, Craig; Blake, Kimberly; Fang, Xi; Ju, Susan; Vann, Nikolas C.; Schwartz, Jill; Doncel, Gustavo F. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 89:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗